Alopecia in patients with COVID-19: A systematic review and meta-analysis.
JAAD Int
; 7: 67-77, 2022 Jun.
Article
in English
| MEDLINE | ID: covidwho-1703008
ABSTRACT
BACKGROUND:
COVID-19 is associated with androgenetic alopecia (AGA), telogen effluvium (TE), and alopecia areata (AA). No studies have analyzed the aggregate data to date.OBJECTIVE:
We conducted a systematic review to characterize the types, incidence, timing, and clinical outcomes of COVID-19-associated alopecia.METHODS:
We searched PubMed/MEDLINE, Scopus, and Embase for articles published between November 2019 and August 2021 using the key words "alopecia" or "hair" and COVID-19-related search terms, identifying 41 original articles describing patients with alopecia and COVID-19.RESULTS:
The current review included 1826 patients with alopecia and COVID-19 (mean age, 54.5 years; 54.3% male). The most common types of alopecia identified were AGA (30.7%, 86.4% male), TE (19.8%, 19.3% male), and AA (7.8%, 40.0% male). AGA preceded COVID-19 symptoms. TE was usually newly triggered by COVID-19 (93.6%). AA usually occurred in patients with preexisting disease (95.1%).LIMITATIONS:
Definitions of COVID-19 onset varied. Studies differed in methodology and were susceptible to reporting and sampling bias. Studies with large sample sizes may exert a disproportionate influence on data.CONCLUSION:
AGA may be a risk factor for severe COVID-19, whereas TE presents as a sequela of COVID-19. AA generally occurs as a relapse in patients with preexisting alopecia.
AA, alopecia areata; ADT, androgen-deprivation therapy; AE, anagen effluvium; AGA, androgenetic alopecia; COVID-19; PA, pressure-induced alopecia; SARS-CoV-2; TE, telogen effluvium; alopecia; alopecia areata; anagen effluvium; androgenetic alopecia; coronavirus disease 2019; hair loss; telogen effluvium
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Observational study
/
Prognostic study
/
Reviews
/
Systematic review/Meta Analysis
Topics:
Long Covid
Language:
English
Journal:
JAAD Int
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS